StairMed develops implantable BCI technology for motor restoration, speech-related applications, and neurological disease intervention. The company is based in Shanghai and focuses on ultra-flexible micro-nano electrodes, wireless implant systems, decoding software, and surgical support tools for clinical translation.

Its platform combines a wireless high-throughput implant, ultra-flexible electrodes, neural signal acquisition, brain-control software, and proprietary implantation robotics. Public materials describe clinical validation of brain-controlled interaction functions and a 256-channel wireless invasive BMI system implanted using the company’s surgical robot.

StairMed is advancing clinical programs in China, with NMPA Green Channel status for its invasive BMI system and larger patient implants planned as part of its registration process. The company is best understood as a vertically integrated Chinese BCI developer linking neural-interface hardware, surgical deployment, and clinical workflow development.